Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions

Details for Australian Patent Application No. 2011202060 (hide)

Owner Allergan, Inc.

Inventors Donello, John E.; Gil, Daniel W.

Agent Davies Collison Cave

Pub. Number AU-A-2011202060

Parent 2004279336

Filing date 4 May 2011

Wipo publication date 26 May 2011

International Classifications

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/4168 (2006.01)

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

19 May 2011 Complete Application Filed

26 May 2011 Application Open to Public Inspection

  Published as AU-A-2011202060

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011202061-Method and circuit for detecting highvoltage discharge of a gas-actuated fastener-driving gun

2011202059-Phosphatase inhibitor sample collection system